False-positive mammogram results linked to spike in anxiety prescriptions

July 6, 2017, Pennsylvania State University
Credit: Getty Images

Women who experience a false-positive mammogram result are more likely to begin medication for anxiety or depression than women who received an immediate negative result, according to a study led by Penn State researcher Joel Segel. The finding highlights the importance of swift and accurate follow-up testing to rule out a breast cancer diagnosis.

The study found that patients who receive a false-positive mammogram result are also prescribed anxiety or depression at a rate 10 to 20 percent higher than patients who receive an immediate negative result. These prescriptions are new and not continuations of previously prescribed medicines.

A false-positive result is one where a suspicious finding on the mammogram leads to additional testing that does not end up leading to a breast cancer diagnosis.

Additionally, within that group of patients who required more than one test to resolve the false-positive there was a 20 to 30 percent increase in those beginning to take anxiety or depression medications. The increase was particularly noticeable among with commercial insurance who required multiple tests to rule out a breast cancer diagnosis.

"The results suggest that efforts to quickly resolve initially positive findings including same-day follow-up tests may help reduce anxiety and even prevent initiation of anxiety or depression medication," said Segel, assistant professor of health policy and administration at Penn State.

This study demonstrates that some women who experience a false-positive mammogram may need additional follow-up care to effectively handle the increased anxiety that may accompany the experience, Segel said.

More importantly, from a practitioner standpoint, the study identifies sub-populations who may be most at risk of increased anxiety following a false-positive mammogram, Segel said. Specifically, women whose false-positive result requires more than one follow-up test to resolve, women with commercial insurance who undergo a biopsy, women who wait longer than one week to receive a negative result, and women who are under age 50 may all be at higher risk of experiencing clinically significant anxiety or depression.

"Regular breast cancer screening is critical to early detection," Segel said. "Patients should continue to work with their providers to ensure they are receiving guideline-appropriate screening and should follow up with their providers if they experience either anxiety or depression following screening or any type of care."

Researchers studied commercial- and Medicaid-claims databases to identify women ages 40 to 64 who underwent screening mammography with no prior claims for or medications.

The findings recently appeared in Medical Care.

Explore further: Women who have a false positive screening mammogram more likely to delay next screen

More information: Joel E. Segel et al. The Effect of False-positive Mammograms on Antidepressant and Anxiolytic Initiation, Medical Care (2017). DOI: 10.1097/MLR.0000000000000760

Related Stories

Women who have a false positive screening mammogram more likely to delay next screen

February 9, 2017
Women who had a false positive result from a screening mammogram were more likely to delay or forgo their subsequent screening mammogram than women who had a true negative result.

Women's adherence to breast cancer screening guidelines varies following false-positive mammogram

April 22, 2016
Depending on when they received their last mammogram, women who receive a false-positive result are more or less likely to get screened at recommended intervals, according to preliminary findings from a University of North ...

False-positive mammograms may indicate increased risk of breast cancer later

December 2, 2015
Main Finding(s): Women with a history of a false-positive mammogram result may be at increased risk of developing breast cancer for up to 10 years after the false-positive result.

False-positive mammograms can trigger long-term distress

March 19, 2013
(HealthDay)—Women who have a false-positive mammogram result—when breast cancer is first suspected but then dispelled with further testing—can have lingering anxiety and distress up to three years after the misdiagnosis, ...

False-positive mammogram result traumatic for most women, study finds

August 26, 2015
(HealthDay)—In a finding that won't surprise many who've been through this ordeal, researchers say emotional turmoil is common for women whose mammogram falsely suggests they have breast cancer.

False-positive mammograms don't deter women from future screening, study finds

April 21, 2014
(HealthDay)—False-positive mammograms do increase anxiety, but the feeling is short-lived and most women go on to have breast screening in the future, new research suggests.

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.